Dr Ulf Grawunder | Chief Executive Officer
NBE Therapeutics

Dr Ulf Grawunder, Chief Executive Officer, NBE Therapeutics

Ulf Grawunder is a Biotech entrepreneur with more than 15 years in the Biotech industry. He is CEO of NBE-Therapeutics which he founded in 2012. Prior to that, Ulf was co-founder of 4-Antibody, a Swiss therapeutic antibody engineering company, where he initially served as CEO and later as CSO, until its trade-sale to US-based Agenus. Ulf is a Biochemist by training with a PhD in Immunology from the Basel Institute for Immunology. Before becoming a Biotech entrepreneur in 2004, he was a post-doctoral researcher at Washington University School of Medicine, St. Louis, and the University of Southern California, Los Angeles, and a principal investigator at the Basel Institute for Immunology and the University of Basel, Switzerland.
Ulf also holds a Diploma of Technology Entrepreneurship from the University St. Gallen, School of Business, Switzerland (HSG, Hochschule St. Gallen).
Ulf also serves as Vice President of the Swiss Biotech Association (www.swissbiotech.org).

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates